Sarepta Therapeutics (SRPT) Research & Development (2010 - 2026)
Sarepta Therapeutics (SRPT) posted Research & Development of $91.26 million for Q2 2026, down 55.4% from $204.39 million a year earlier and down 40.7% from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Sarepta Therapeutics was $789.44 million, down 43.7% year-over-year; for FY2025, it was $1.52 billion, up 89.2% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
- In prior years, Sarepta Therapeutics' Research & Development was $804.52 million in FY2024 (-8.3%), $877.39 million in FY2023 (unchanged), $877.09 million in FY2022 (+13.7%) and $771.18 million in FY2021 (+6.8%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development since Q1 2019.
- On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 30.3%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q1 2025, with growth of 286.0%; the weakest was Q1 2026, with a decline of 80.1%.
- According to Business Quant data, Research & Development for the three prior quarters was $153.96 million (Q1 2026), $325.34 million (Q4 2025) and $218.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Sarepta Therapeutics | 1.99 Bn | -1.25 Bn | 251.87 Mn | 91.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.26 Mn |
| Mar 31, 2026 | 153.96 Mn |
| Dec 31, 2025 | 325.34 Mn |
| Sep 30, 2025 | 218.89 Mn |
| Jun 30, 2025 | 204.39 Mn |
| Mar 31, 2025 | 773.45 Mn |
| Dec 31, 2024 | 199.95 Mn |
| Sep 30, 2024 | 224.48 Mn |
| Jun 30, 2024 | 179.69 Mn |
| Mar 31, 2024 | 200.40 Mn |
| Dec 31, 2023 | 195.52 Mn |
| Sep 30, 2023 | 194.30 Mn |
| Jun 30, 2023 | 241.89 Mn |
| Mar 31, 2023 | 245.68 Mn |
| Dec 31, 2022 | 213.80 Mn |
| Sep 30, 2022 | 216.71 Mn |
| Jun 30, 2022 | 252.33 Mn |
| Mar 31, 2022 | 194.25 Mn |
| Dec 31, 2021 | 197.30 Mn |
| Sep 30, 2021 | 139.12 Mn |
API Access
Sarepta Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();